Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Improved Quality of Life With CagriSema in People with Overweight or Obesity and Poor Physical Function at Baseline: A Post Hoc Analysis of the REDEFINE 1 Trial
Authors:
Domenica Rubino1; Jaime P. Almandoz2; Christine Poitou3,4; Tobias Freyberg Justesen5; Ronette L. Kolotkin6-9; Cindy Pau10; Lisa von Huth Smith5; Zara Rebecca Stisen5; Niels Zeuthen5; Kirsi H. Pietiläinen11,12
Affiliations
Post Hoc<\/i> Analysis of the REDEFINE 1 Trial\n`)" v-cloak>
View DetailsHide Details